{"data":[{"accessionNo":"0002012383-26-001939","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001434316","issuerName":"FATE THERAPEUTICS INC","ticker":"FATE","cusip":"31189P102","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2194284,"percentOfClass":1.9,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/fate"},{"accessionNo":"0001104659-26-047066","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001434316","issuerName":"FATE THERAPEUTICS INC","ticker":"FATE","cusip":"31189P102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-20","reportingPerson":"Redmile Group, LLC","reportingCik":"0001425738","personType":"IA,OO","sharesOwned":18229078,"percentOfClass":14.9,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/fate"},{"accessionNo":"0001104659-26-047066","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001434316","issuerName":"FATE THERAPEUTICS INC","ticker":"FATE","cusip":"31189P102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-20","reportingPerson":"Jeremy C. Green","reportingCik":"0001650527","personType":"IN,HC","sharesOwned":18229078,"percentOfClass":14.9,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/fate"},{"accessionNo":"0001104659-26-047066","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001434316","issuerName":"FATE THERAPEUTICS INC","ticker":"FATE","cusip":"31189P102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-20","reportingPerson":"RedCo II Offshore SPV LLC","reportingCik":"0002129575","personType":"OO","sharesOwned":10144307,"percentOfClass":8.5,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/fate"},{"accessionNo":"0001104659-26-047066","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001434316","issuerName":"FATE THERAPEUTICS INC","ticker":"FATE","cusip":"31189P102","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-04-20","reportingPerson":"RedCo II Master Fund, L.P.","reportingCik":"0001921783","personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-04-22","canonicalUrl":"https://xoomar.com/markets/stocks/fate"},{"accessionNo":"0000102909-26-001228","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001434316","issuerName":"Fate Therapeutics Inc","ticker":"FATE","cusip":"31189P102","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/fate"}],"updatedAt":"2026-11-04T06:02:49.629Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/fate","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}